Shares of Globus Medical (GMED) tumbled 14.44% in after-hours trading on Thursday following the release of the company's first-quarter 2025 financial results, which fell short of analyst expectations.
The medical device company reported adjusted earnings per share (EPS) of $0.68, missing the analyst consensus estimate of $0.74 by 8.11%. This represents a 5.56% decrease compared to the same period last year when the company reported earnings of $0.72 per share. Globus Medical's quarterly sales also disappointed, coming in at $598.12 million, 4.44% below the analyst consensus estimate of $625.90 million. The reported sales figure marks a 1.41% decrease from the $606.67 million recorded in the same quarter of the previous year.
The company's net income for the quarter stood at $75.5 million, with a reported EPS of $0.54. The significant gap between Wall Street's expectations and Globus Medical's actual performance likely triggered the sharp sell-off in the stock during after-hours trading. Investors appear to be concerned about the company's growth trajectory and its ability to meet market expectations in the current economic environment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.